Kiwok Nordic AB

Founded in 2003, Kiwok a MedTech company has developed BodyKom, a Remote Patient Monitoring service for ECG. The solution is based on a mobile accessed, body close sensor technology and cloud service. BodyKom measures data, compares data to rules, triggers activities on deviation from the rules and distributes diagnosis data to healthcare providers. In short, Kiwok enables patients to be mobile and perform everyday activities, yet still be under medical observation. Since the product enables healthcare providers to monitor patients on a long-term, continuous, real-time basis, BodyKom results in earlier diagnosis, more effective treatment, better follow-up, higher care quality and hence lower costs. Kiwok is granted method patents in the US and Korea. The product is developed in cooperation with Karolinska University Hospital in Sweden.

Anyone who was a shareholder in Kiwok Nordic AB on the record date of September 28, 2026 has preferential rights to subscribe for shares, in relation to previous shareholdings. Anyone who is a registered shareholder on the record date shall recieve one (1) subscription right for each held share regardless series in Kiwok Nordic AB. To subscribe for one (1) new B-share at the subscription price of 2.00 SEK per share, four (4) subscription rights are needed. For subscription without subscription rights, the above registration form can be used. When subscribing via ISK/KF accounts, subscription must be made in agreement with the bank/custodian where the account is located.